Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.310
+0.300 (14.93%)
At close: Nov 22, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Nov 22, 2024, 6:39 PM EST
Inhibikase Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -19.57 | -19.03 | -18.05 | -14.79 | -2.85 | -5.72 | |
| Depreciation & Amortization | 0.03 | 0.18 | 0.01 | - | - | - | |
| Other Amortization | - | - | - | - | - | 1.59 | |
| Stock-Based Compensation | 0.35 | 0.5 | 0.46 | 1.53 | 0.57 | 1.44 | |
| Other Operating Activities | 0.01 | 0.03 | 0.07 | 0.72 | 1.61 | 0.72 | |
| Change in Accounts Receivable | - | 0.04 | 0.07 | -0.11 | - | 0.47 | |
| Change in Accounts Payable | 1.24 | -0.5 | 0.06 | -0.63 | -0.25 | 0.05 | |
| Change in Unearned Revenue | - | - | - | -2.33 | 0.9 | 1.17 | |
| Change in Other Net Operating Assets | 0.68 | 0.7 | 0.04 | 1.3 | -1.11 | -0.05 | |
| Operating Cash Flow | -17.24 | -18.09 | -17.35 | -14.3 | -1.13 | -0.34 | |
| Capital Expenditures | - | -0.01 | -0.24 | - | - | - | |
| Investment in Securities | -0.36 | 11.67 | -15.76 | - | - | - | |
| Investing Cash Flow | -0.36 | 11.66 | -16.01 | - | - | - | |
| Long-Term Debt Issued | - | - | - | - | 0.27 | - | |
| Total Debt Issued | - | - | - | - | 0.27 | - | |
| Long-Term Debt Repaid | - | - | -0.25 | -0.04 | - | -0.02 | |
| Total Debt Repaid | - | - | -0.25 | -0.04 | - | -0.02 | |
| Net Debt Issued (Repaid) | - | - | -0.25 | -0.04 | 0.27 | -0.02 | |
| Issuance of Common Stock | 3.79 | 8.54 | 0.04 | 41.21 | 14.79 | - | |
| Repurchase of Common Stock | - | - | - | -0.08 | - | - | |
| Other Financing Activities | -0.14 | -0.14 | - | - | - | - | |
| Financing Cash Flow | 3.66 | 8.41 | -0.2 | 41.09 | 15.06 | -0.02 | |
| Net Cash Flow | -13.95 | 1.98 | -33.56 | 26.8 | 13.94 | -0.36 | |
| Free Cash Flow | -17.24 | -18.1 | -17.59 | -14.3 | -1.13 | -0.34 | |
| Free Cash Flow Margin | -1724492300.00% | -6947.87% | -14253.37% | -461.11% | -161.69% | -30.13% | |
| Free Cash Flow Per Share | -2.64 | -3.39 | -4.17 | -4.71 | -0.83 | -0.25 | |
| Cash Interest Paid | - | - | 0 | 0 | 0.01 | 0.01 | |
| Levered Free Cash Flow | -10.14 | -12.17 | -10.97 | -9.47 | -1.49 | 1.07 | |
| Unlevered Free Cash Flow | -10.14 | -12.17 | -10.97 | -9.46 | -1.48 | 1.09 | |
| Change in Net Working Capital | -1.87 | 0.28 | -0.14 | 1.76 | 0.29 | -1.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.